News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
BSMO Highlights Need for Sustainable Support in Belgium’s Precision Oncology Efforts
Photo: Depositphotos
May 9, 2025, 10:42

BSMO Highlights Need for Sustainable Support in Belgium’s Precision Oncology Efforts

Belgian Society of Medical Oncology (BSMO) posted on LinkedIn:

“Belgium is advancing precision oncology through national and regional tumor boards supported by the BSMO, with studies proving the value of broad genomic profiling. The first results of the BALLETT study were recently published. However, sustainable support and reimbursement for these efforts remain critical.”

Title: A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

Authors: Pieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, Geert Martens, Jean-Luc Canon, Gabriela Beniuga, Guy Froyen, Jacques Van Huysse, Rebecca De Pauw, Hans Prenen, Suzan Lambin, Lore Decoster, Freya Vaeyens, Sylvie Rottey, Pieter-Jan Van Dam, Lynn Decoster, Annemie Rutten, Max Schreuer, Siebe Loontiens, Joni Van der Meulen, Jeroen Mebis, Kristof Cuppens, Sabine Tejpar, Isabelle Vanden Bempt, Brigitte Maes

Read The Full Article at NPJ.

BSMO Highlights Need for Sustainable Support in Belgium’s Precision Oncology Efforts

Annemie Rutten BALLETT study Brigitte Maes BSMO cancer Franceska Dedeurwaerdere Freya Vaeyens Gabriela Beniuga Geert Martens Guy Froyen Hans Prenen Isabelle Vanden Bempt Jacques Van Huysse Jean-Luc Canon Jeroen Mebis Joni Van der Meulen Kristof Cuppens Lore Decoster Lynn Decoster Max Schreuer OncoDaily Oncology Philippe Aftimos Pieter-Jan Van Dam Pieter-Jan Volders Rebecca De Pauw Sabine Tejpar Siebe Loontiens Suzan Lambin Sylvie Rottey
Special Coverage
Blog
May 9, 2025, 10:42
BSMO Highlights Need for Sustainable Support in Belgium’s Precision Oncology Efforts
Blog
May 9, 2025, 10:37
Yuji Uehara: Thrilled to Receive a Travel Grant for ESMO TAT Asia25
Blog
May 9, 2025, 10:32
Julie Torode Believes That Collaboration Is Key to Ending Global Ovarian Cancer Inequities - World Ovarian Cancer Coalition
Blog
May 9, 2025, 10:29
Cathy Eng: Polyps Removed, so Back Again in 3 years
Blog
May 9, 2025, 10:15
Sarah Sammons Comments on TDXd Use in Early HER2+ Breast Cancer
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC